Want to see JP:4218 full AI Analyst Report?
4218 Stock Chart & Stats
¥1998.00
-¥13.00(-0.63%)
At close: 4:00 PM EST
¥1998.00
-¥13.00(-0.63%)
Day’s Range― - ―
52-Week Range¥1,781.00 - ¥2,038.00
Previous CloseN/A
Volume9.80K
Average Volume (3M)13.87K
Market Cap
¥39.31B
Enterprise Value¥25.47B
Total Cash (Recent Filing)¥14.13B
Total Debt (Recent Filing)¥2.17B
Price to Earnings (P/E)23.4
Beta0.48
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.77%
Share Statistics
EPS (TTM)81.21
Shares Outstanding20,738,007
10 Day Avg. Volume15,410
30 Day Avg. Volume13,873
Financial Highlights & Ratios
PEG Ratio-1.48
Price to Book (P/B)0.86
Price to Sales (P/S)0.76
P/FCF Ratio77.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)81.3
Revenue Forecast (FY)¥52.02B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and rising equity provide durable financial flexibility: reduces refinancing and solvency risk, supports investment or cushioning in downturns, and preserves capacity for strategic capex or M&A without jeopardizing core operations over the next several months.
Steady Revenue GrowthConsistent top-line expansion across 2021–2026 signals resilient demand across industrial, medical and consumer channels. Durable revenue momentum enhances scale benefits, supports product investment, and reduces dependency on any single short-term market fluctuation.
Consistent Positive Operating Cash FlowPositive operating cash flow every year indicates underlying cash generation capacity, enabling working-capital management, routine capex and dividend funding. While lower than prior peaks, persistent cash generation supports operational continuity and strategic initiatives.
Bears Say
Weakened Profitability And MarginsDeclining net income and recent operating profit drops point to margin compression or rising costs. Sustained weaker profitability reduces internal investment capacity, limits reinvestment and dividend growth, and risks undermining long-term competitiveness if structural cost pressures persist.
Volatile Free Cash FlowLarge swings in free cash flow complicate capital-allocation planning and make sustained funding for buybacks, capex or acquisitions less reliable. This variability increases execution risk and reduces predictability of shareholder distributions over the medium term.
Modest Shareholder Returns / Low ROEMid-single-digit ROE indicates limited ability to convert equity into high earnings growth relative to peers. Persistently low returns can constrain investor appeal and suggest structural margin or pricing limitations in core adhesive markets over the coming months.
Nichiban Co., Ltd. News
4218 FAQ
What was Nichiban Co., Ltd.’s price range in the past 12 months?
Nichiban Co., Ltd. lowest stock price was ¥1781.00 and its highest was ¥2038.00 in the past 12 months.
What is Nichiban Co., Ltd.’s market cap?
Nichiban Co., Ltd.’s market cap is ¥39.31B.
When is Nichiban Co., Ltd.’s upcoming earnings report date?
Nichiban Co., Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 27 days.
How were Nichiban Co., Ltd.’s earnings last quarter?
Nichiban Co., Ltd. released its earnings results on May 14, 2026. The company reported ¥18.99 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Nichiban Co., Ltd. overvalued?
According to Wall Street analysts Nichiban Co., Ltd.’s price is currently Overvalued.
Does Nichiban Co., Ltd. pay dividends?
Nichiban Co., Ltd. pays a Annually dividend of ¥40 which represents an annual dividend yield of 1.77%. See more information on Nichiban Co., Ltd. dividends here
What is Nichiban Co., Ltd.’s EPS estimate?
Nichiban Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nichiban Co., Ltd. have?
Nichiban Co., Ltd. has 20,738,007 shares outstanding.
What happened to Nichiban Co., Ltd.’s price movement after its last earnings report?
Nichiban Co., Ltd. reported an EPS of ¥18.99 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.596%.
Which hedge fund is a major shareholder of Nichiban Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4218
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nichiban Co., Ltd.
Nichiban Co., Ltd. operates as a manufacturer and distributor of medical supplies and various adhesive tapes across Asian and European markets. Its range of medical offerings encompasses products like surgical and dressing tapes, alongside first-aid and hemostatic bandages. The company also provides over-the-counter (OTC) solutions, which include anti-inflammatory patches, foot care items, waterproof films, and general bandages. For athletic and support needs, Nichiban supplies an assortment of taping products such as cotton, elastic, kinesiology, and strapping tapes. Within its stationery division, the company offers cellulose adhesive tapes, double-sided tapes, adhesive transfer tapes, and book-binding tapes. Furthermore, Nichiban produces industrial tapes tailored for diverse applications, including non-heavy-duty packaging, carton sealing, agricultural use, vehicles, and machinery, in addition to specialized tape solutions. The company's tape portfolio also features cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Founded in 1918, Nichiban Co., Ltd. maintains its headquarters in Tokyo, Japan.
Technical Analysis
Kokuyo Co
―
Pilot Corporation
―
King Jim Co., Ltd.
―
LIHIT LAB., INC.
―
Mitsubishi Pencil Company, Limited
―
Options Prices
Currently, No data available
---